Global Therapeutic Drug Monitoring Market 2017-2021; New Report Launched

DrugPipeline.net has announced the addition of “Global Therapeutic Drug Monitoring Market 2017-2021” research report to their website DrugPipeline.net

Logo

Bangalore, Karnataka -- (SBWire) -- 04/27/2017 --Therapeutic drug monitoring is a branch of clinical pharmacology and clinical chemistry that specializes in the measurement of drug concentration in blood. It is mainly performed on the drugs with a narrow therapeutic window. Therapeutic drug monitoring aims at improving patient care by regulating the dose of drugs. It is based on a priori pharmacogenetic, demographic, and clinical information. It also considers a posteriori measurement of drug concentration in the blood.

Report forecast the global therapeutic drug monitoring market to grow at a CAGR of 7.5% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global therapeutic drug monitoring market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Therapeutic Drug Monitoring Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Beckman Coulter
- Bio-Rad Laboratories
- F. Hoffmann-La Roche
- Siemens Healthcare
- Thermo Fisher Scientific

Other prominent vendors
- Adaptive Biotechnologies
- AESKU.Diagnostics
- Alere
- bioMérieux
- Bio-Techne
- BÜHLMANN Laboratories
- DiaSorin
- Euro Diagnostica
- Exagen Diagnostics
- IDEXX Laboratories
- InSource Diagnostics
- Merck Millipore
- Miraca Life Sciences
- Myriad Genetics
- Phadia
- Quest Diagnostics
- SEKISUI MEDICAL
- SQI Diagnostics
- Tecan
- Theradiag

Market driver
- Increasing demand for personalized medicine
- For a full, detailed list, view our report

Market challenge
- Shortage of skilled technicians for performing diagnostic techniques
- For a full, detailed list, view our report

Market trend
- Advent of POC tests
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 70 pages "Global Therapeutic Drug Monitoring Market 2017-2021" report covers Executive summary, Scope of the report, Research Methodology, Introduction, An overview of therapeutic drug monitoring, Market landscape, Market segmentation by product type, Market segmentation by drug class, Market segmentation by end-users, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-therapeutic-drug-monitoring-market-2017-2021

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.

Media Relations Contact

Sudeep Chakravarty
Director - Operations
DrugPipeline.net
http://www.drugpipeline.net/technavio/global-therapeutic-drug-monitoring-market-2017-2021

View this press release online at: http://rwire.com/800170